TOWER BRIDGE ADVISORS - NOVARTIS A G ownership

NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,122 filers reported holding NOVARTIS A G in Q1 2022. The put-call ratio across all filers is 0.55 and the average weighting 0.2%.

Quarter-by-quarter ownership
TOWER BRIDGE ADVISORS ownership history of NOVARTIS A G
ValueSharesWeighting
Q3 2023$9,379,065
-0.3%
92,078
-1.2%
0.87%
+0.7%
Q2 2023$9,405,720
-3.2%
93,209
-11.8%
0.86%
+8.3%
Q1 2023$9,719,708
-0.9%
105,649
-2.3%
0.80%
-2.3%
Q4 2022$9,808,646
-99.9%
108,120
-2.3%
0.82%
+9.1%
Q3 2022$8,410,507,000
-12.4%
110,650
-2.6%
0.75%
-4.6%
Q2 2022$9,606,243,000
-4.9%
113,643
-1.3%
0.78%
+15.8%
Q1 2022$10,106,080,000
-3.0%
115,169
-3.3%
0.68%
+5.6%
Q4 2021$10,418,552,000
-7.1%
119,110
-13.1%
0.64%
-14.4%
Q3 2021$11,211,547,000
-12.0%
137,094
-1.8%
0.75%
-11.9%
Q2 2021$12,740,845,000
+4.8%
139,641
-1.8%
0.85%
-7.2%
Q1 2021$12,153,974,000
-11.5%
142,185
-2.3%
0.92%
-18.2%
Q4 2020$13,736,543,000
+10.8%
145,468
+2.1%
1.12%
-11.6%
Q3 2020$12,393,800,000
+2.2%
142,523
+2.7%
1.27%
-6.9%
Q2 2020$12,125,412,000
+12.8%
138,830
+6.5%
1.36%
-3.5%
Q1 2020$10,745,214,000
-6.0%
130,324
+7.9%
1.41%
+16.7%
Q4 2019$11,435,427,000
+13.8%
120,767
+6.2%
1.21%
+9.8%
Q3 2019$10,049,348,000
-1.1%
113,719
+2.2%
1.10%
-3.3%
Q2 2019$10,162,255,000
-4.8%
111,294
+0.3%
1.14%
-8.2%
Q1 2019$10,671,925,000
+12.7%
111,004
+0.6%
1.24%
+1.6%
Q4 2018$9,471,622,000
-0.3%
110,379
+0.1%
1.22%
+23.0%
Q3 2018$9,498,278,000
+19.3%
110,240
+4.6%
0.99%
+11.7%
Q2 2018$7,961,538,000
-9.9%
105,395
-3.6%
0.89%
-9.4%
Q1 2018$8,840,867,000
+1.0%
109,349
+4.9%
0.98%
+4.5%
Q4 2017$8,749,472,000
+3.1%
104,210
+5.4%
0.94%
-2.8%
Q3 2017$8,488,333,000
+11.2%
98,874
+8.1%
0.96%
+10.3%
Q2 2017$7,635,585,000
-6.9%
91,477
-17.1%
0.88%
-8.6%
Q1 2017$8,199,185,000
-9.1%
110,397
-10.9%
0.96%
-12.5%
Q4 2016$9,024,148,000
-31.1%
123,890
-25.3%
1.09%
-31.4%
Q3 2016$13,090,463,000
-3.8%
165,786
+0.5%
1.59%
-6.0%
Q2 2016$13,612,087,000
+15.6%
164,975
+1.5%
1.70%
+15.3%
Q1 2016$11,778,961,000
-12.8%
162,603
+3.6%
1.47%
-16.4%
Q4 2015$13,501,397,000
-3.2%
156,920
+3.4%
1.76%
-8.4%
Q3 2015$13,950,147,000
-6.0%
151,764
+0.6%
1.92%
+2.3%
Q2 2015$14,838,916,000
-0.6%
150,894
-0.3%
1.88%
-0.7%
Q1 2015$14,923,736,000
+15.3%
151,341
+8.3%
1.89%
+18.8%
Q4 2014$12,948,864,000
-0.7%
139,746
+0.8%
1.59%
-3.3%
Q3 2014$13,046,041,000
+2.1%
138,596
-1.8%
1.65%
+4.4%
Q2 2014$12,779,849,000
+4.2%
141,167
-2.2%
1.58%0.0%
Q1 2014$12,268,641,000
+6.7%
144,303
+0.9%
1.58%
+4.4%
Q4 2013$11,501,253,000
+4.6%
143,086
-0.2%
1.51%
-4.2%
Q3 2013$10,993,847,000
+8.7%
143,317
+0.2%
1.58%
+5.2%
Q2 2013$10,113,086,000143,0221.50%
Other shareholders
NOVARTIS A G shareholders Q1 2022
NameSharesValueWeighting ↓
GODSEY & GIBB, INC 184,900$15,121,0006.74%
Martin Investment Management, LLC 289,924$23,710,0005.98%
Camber Capital Management LP 2,000,000$163,560,0005.04%
MANAGED ASSET PORTFOLIOS, LLC 381,778$31,222,0004.76%
PROFESSIONAL ADVISORY SERVICES INC 267,779$21,899,0003.22%
SCHARF INVESTMENTS, LLC 1,244,711$101,794,0003.21%
GARLAND CAPITAL MANAGEMENT INC 50,755$4,151,0002.97%
First Fiduciary Investment Counsel, Inc. 167,378$13,688,0002.67%
WILKINS INVESTMENT COUNSEL INC 130,590$10,680,0002.61%
Lowell Blake & Associates Inc. 66,309$5,423,0002.52%
View complete list of NOVARTIS A G shareholders